PPARG and lipodystrophy: In mice, activation of PPARγ specifically in adipocytes is sufficient to cause whole-body insulin sensitisation and, conversely, a dominant-negative mutation in a single allele of PPARG in humans leads to partial lipodystrophy and insulin resistance, supporting its role in adipogenesis and insulin sensitivity [21–24].